Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Tax Provisions (2016 - 2025)

Lipocine's Tax Provisions history spans 12 years, with the latest figure at $200.0 for Q1 2025.

  • For Q1 2025, Tax Provisions changed 0.0% year-over-year to $200.0; the TTM value through Sep 2025 reached $200.0, down 83.82%, while the annual FY2024 figure was $681.0, 9.8% down from the prior year.
  • Tax Provisions reached $200.0 in Q1 2025 per LPCN's latest filing, down from $481.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $555.0 in Q4 2023 to a low of $200.0 in Q1 2021.
  • Average Tax Provisions over 5 years is $314.62, with a median of $200.0 recorded in 2021.
  • Peak YoY movement for Tax Provisions: changed 0.0% in 2021, then rose 15.38% in 2023.
  • A 5-year view of Tax Provisions shows it stood at $200.0 in 2021, then surged by 140.5% to $481.0 in 2022, then increased by 15.38% to $555.0 in 2023, then dropped by 13.33% to $481.0 in 2024, then plummeted by 58.42% to $200.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Tax Provisions are $200.0 (Q1 2025), $481.0 (Q2 2024), and $200.0 (Q1 2024).